GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lonza Group LONN.SW · CHF

Health Care · Life Sciences Tools & Services · SIX · 🇨🇭 Switzerland

Compare

659.40

-0.60%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Lonza Group — daily SIX:LONN End of day
Market value
CHF 46.06bn
Last close × shares
Volume
184.4k
Shares, 9 Nov 2026
Price to earnings
51.1
Dividend yield
0.38%

About Lonza Group

Its shares trade on SIX under the ticker LONN.SW. It has been listed since 3 April 2002. In the fiscal year to 31 December 2025, it reported revenue of CHF 6.53bn and net income of CHF 949.0m. At that date it held total assets of CHF 18.97bn and shareholders' equity of CHF 9.13bn.

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. The company is headquartered in Basel, Basel-Stadt. The company went IPO on 2002-04-03. The firm's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The firm divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.

Figures and description from our data supplier, not checked against the company's own report.

More about Lonza Group →

Latest on Lonza Group

Our reporting

Next results

27 Jan 2027

Due on 27 Jan 2027. Analysts expect earnings of 9.25 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Lonza Group's ticker?

Lonza Group trades as LONN.SW on SIX, under ISIN CH0013841017.

What was Lonza Group's last closing price?

659.40 on 9 Nov 2026. The figure is in CHF and is never converted.

When does Lonza Group next report results?

Results are expected on 27 Jan 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.